Transcriptomics

Dataset Information

0

Carbonic Anhydrase 12 is a Novel Prognostic Biomarker and Therapeutic Target for High-Risk Follicular Thyroid Cancer


ABSTRACT: Identifying high-risk follicular thyroid cancer (FTC) is critical for stratified treatment and developing targeted therapies. This study performed RNA sequencing on high-risk FTC, identifying Carbonic Anhydrase 12 (CA12) as a promising biomarker. High CA12 expression predicted poor disease-free survival, surpassing conventional markers. In vitro, CA12 knockdown reduced proliferation and invasion, while a CA12 inhibitor showed synergistic anti-proliferative effects with Lenvatinib. These findings establish CA12 as both a novel prognostic biomarker and a potential therapeutic target for FTC.

ORGANISM(S): Homo sapiens

PROVIDER: GSE305211 | GEO | 2026/01/14

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

| PRJEB98652 | ENA
2012-03-25 | GSE36625 | GEO
2012-03-25 | E-GEOD-36625 | biostudies-arrayexpress
2020-10-28 | GSE115445 | GEO
2024-06-10 | E-MTAB-14111 | biostudies-arrayexpress
| PRJNA1304766 | ENA
| PRJNA473154 | ENA
| PRJNA762934 | ENA
2022-03-17 | GSE184062 | GEO
| PRJNA717263 | ENA